You will be expected to have a strong scientific and clinical research background and be able to take a lead role in the clinical and scientific responsibilities of oncology clinical trials.

Key Responsibilities:

• Provide strategic leadership for the development of an asset or portfolio of assets.
• Execute the broad strategy and vision of the organization through the leadership of a multi-disciplinary matrix team within the R&D organization.
• Help to define and mitigate key development risks of a compound.
• Work closely with functional lines to evaluate and identify key clinical and pre-clinical data required for decisions around medicine development.
• Facilitator of decision-making both within the project team and with external stake-holders.
• Accountable for quality, timely, and on-budget delivery of the asset clinical development plan and studies
• Direct study responsibility, if required
• Collaboration with the MDL & PPL(s) to plan and implement strategy to address asset program requirements in alignment with Oncology R&D goals
• Excellence in the clinical research staffs contribution to successful regulatory approvals, reimbursable medicines, and lifecycle management
• Identification and sharing of best practices with oversight for the implementation of these best practices into business processes
• Close collaboration with other matrixed functions for in-stream, end-to-end process flow, document preparation, data review and submissions.
• Creation and fostering of strong strategic partnerships with key internal stakeholders and strategic external partners

• LI-GSK

• Bachelors Degree

• Minimum of 10 years of relevant clinical drug development experience
• Demonstrated ability to lead in a heavily matrixed environment
• Ability to influence staff and stakeholders to adapt to positive change

• Comprehensive knowledge of asset and asset strategy highly recommended